Board of Directors – Mission Therapeutics

Experienced and Dedicated

Board of Directors

Dr Anker Lundemose, MD, Ph.D., DMSc

Chief Executive Officer

Professor Sir Steve Jackson

Founder and Chairman of the Scientific Advisory Board

Graziano Seghezzi

Managing Partner, Sofinnova Partners

Matthew Foy

Partner, SR One

Dr Denis Patrick

VP, Head of Partnering Innovation and Managing Partner of Pfizer Ventures

Dr James B. Summers

Non-Executive Director

Craig Richardson

Partner, IP Group

Dr. Carole Nuechterlein

Head Roche Venture Fund

Jonathan Hepple

Partner, Rosetta Capital